Form 4: scPharmaceuticals CFO Rachael Nokes Reports Stock Option Exercise
SEC Form 4 Filing
Rachael Nokes, CFO and Treasurer of scPharmaceuticals Inc., reports exercising stock options and adjusting previously reported option numbers.
Summary
- On August 6, 2024, Rachael Nokes, CFO and Treasurer of scPharmaceuticals Inc., exercised stock options to acquire 10,445 shares of common stock at a price of $0.00.
- Following the transaction, Nokes directly owns 72,851 shares of scPharmaceuticals Inc.
- The filing also corrects a typographical error in a previous Form 3, adjusting the number of options initially reported.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock option exercises, which is neutral in sentiment.
Industry Context
This is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| February 28, 2019 | Date of the Form 3 filing that contained a typographical error. |
| 08/06/2024 | Date of the stock option exercise. |
| 08/08/2024 | Date of the Form 4 filing. |
| 09/17/2024 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.